
About
BioCogniz is a bioinformatics and contract research organization focused on next-generation sequencing, drug discovery, bioinformatics, and precision medicine. It serves researchers, universities, pharmaceutical companies, and other clients globally, with operations and presence in India, the United States, and Dubai.
Services
AI-Driven Drug Discovery
Uses machine learning, deep learning, and autonomous AI agents for target identification, lead optimization, virtual screening, compound design, and ADMET prediction.
Next-Generation Sequencing (NGS)
Provides whole genome, whole exome, whole transcriptome, microbial, 16S rRNA, and cell-free DNA sequencing for clinical and research applications.
AI-Driven NGS Data Analysis
Performs machine-learning-based analysis of genomic data including variant calling, microbial genome analysis, mitochondrial genome analysis, RNA-seq analysis, and ribosome profiling analysis.
Advanced Bioinformatics
Offers pathway and functional analysis, protein structure prediction, phylogenetic analysis, multi-omics integration, and custom algorithm development.
Precision Medicine Solutions
Provides biomarker discovery and validation, treatment response prediction, companion diagnostics development, pharmacogenomics analysis, and population genetics studies.
Training Programs
Offers workshops, online courses, and one-on-one mentoring through BioCogniz Academy.
Next-Generation Sequencing
Provides whole genome, exome, transcriptome, microbial, 16S rRNA, cell-free DNA, and custom panel sequencing services using Illumina NovaSeq 6000.
- Turnaround
- Within 24 hours · 1-2 weeks · 1-4 weeks · 4-12 weeks · 2-8 weeks · Most projects can begin within 1-2 weeks after initial consultation and project scoping. · NGS analysis (1-4 weeks) · Drug discovery projects (4-12 weeks) · Custom algorithm development (2-8 weeks)
- What to send
- 10ng cfDNA · Raw samples
Capabilities
- Assays and studies
- NGS · Cell-free expression · Whole genome sequencing · Whole exome sequencing · Whole transcriptome sequencing · 16S rRNA sequencing · Cell-free DNA sequencing · Variant calling · ADMET prediction · Virtual screening · Molecular docking · Pathway analysis
8 more
Protein structure prediction · Pharmacogenomics analysis · Exome sequencing · Microbial genome analysis · Mitochondrial genome analysis · RNA sequence analysis · Functional analysis · Phylogenetic analysis - Scale and capacity
- 50+ Projects Completed · 15+ Software Products · 50+ Countries
- Therapeutic areas
- Drug discovery · Genomics · Precision medicine · Cancer · Rare disease · Microbiome · Cancer research
Instruments and platforms
- Illumina NovaSeq 6000
- NextSeq 550
- MiSeq
Modalities and species
- Modalities
- Small molecule
- Species and models
- Bacterial · Viral · Fungal · Human · Microbial samples · Plant samples
Industries served
- Healthcare
- Pharmaceuticals
- Biotechnology
- Academia
- Agriculture
Company
- Type
- CRO
- Founded
- 2024
- Quality
- 95% Accuracy Rate · quality control (sequencing data generation) · encrypted data transfer · secure cloud storage · NDAs · compliance with international data prote
Locations
- Based in
- Chennai, India
- Sites
- Chennai, India · Dubai, UAE · United States, USA · Chennai, Tamil Nadu, India
- Serves
- globally, India, United States, UAE, 50+ Countries, Global
Contacts
- Phone
- +91 9600656740
Similar labs
Work here? Claim this listing